The fifth revision of the (DSM-5) was the most controversial in the manual's history. This review selectively surveys some of the most important changes in DSM-5, including structural/organizational changes, modifications of diagnostic criteria, and newly introduced categories. It analyzes why these changes led to such heated controversies, which included objections to the revision's process, its goals, and the content of altered criteria and new categories. The central focus is on disputes concerning the false positives problem of setting a valid boundary between disorder and normal variation. Finally, this review highlights key problems and issues that currently remain unresolved and need to be addressed in the future, including systematically identifying false positive weaknesses in criteria, distinguishing risk from disorder, including context in diagnostic criteria, clarifying how to handle fuzzy boundaries, and improving the guidelines for “other specified” diagnosis.


Article metrics loading...

Loading full text...

Full text loading...


Literature Cited

  1. Abramowitz JS, Jacoby RJ. 2014. Obsessive-compulsive disorder in the DSM-5. Clin. Psychol. Sci. Pract. 21:221–35 [Google Scholar]
  2. Accad M, Fred HL. 2010. Risk-factor medicine: an industry out of control?. Cardiology 117:64–67 [Google Scholar]
  3. Am. Psychiatr. Assoc 1980. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: Am. Psychiatr. Publ, 3rd ed..
  4. Am. Psychiatr. Assoc 1994. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: Am. Psychiatr. Publ, 4th ed..
  5. Am. Psychiatr. Assoc 2013. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: Am. Psychiatr. Publ, 5th ed..
  6. Axelson D, Findling RL, Fristad MA, Kowatch RA, Youngstrom EA. et al. 2012. Examining the proposed disruptive mood dysregulation disorder diagnosis in children in the Longitudinal Assessment of Manic Symptoms Study. J. Clin. Psychiatry 73:101342–50 [Google Scholar]
  7. Biederman J, Petty CR, Evans M, Small J, Faraone SV. 2010. How persistent is ADHD? A controlled 10-year follow-up study of boys with ADHD. Psychiatry Res. 177:3299–304 [Google Scholar]
  8. Coccaro EF. 2011. Intermittent explosive disorder: development of integrated research criteria for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Compr. Psychiatry 5:119–25 [Google Scholar]
  9. Coccaro EF, Kavoussi RJ, Berman ME, Lish JD. 1998. Intermittent explosive disorder-revised: development, reliability, and validity of research criteria. Compr. Psychiatry 39:368–76 [Google Scholar]
  10. Coccaro EF, Schmidt C, Samuels J, Nestadt G. 2004. Lifetime and 1-month prevalence rates of intermittent explosive disorder in a community sample. J. Clin. Psychiatry 65:820–24 [Google Scholar]
  11. Ding YC, Chi HC, Grady DL, Morishima A, Kidd JR. et al. 2002. Evidence of positive selection acting at the human dopamine receptor D4 gene locus. PNAS 99:309–14 [Google Scholar]
  12. Dunner DL. 1993. A review of the diagnostic status of “bipolar II” for the DSM-IV work group on mood disorders. Depression 1:2–10 [Google Scholar]
  13. Eisenberg DTA, Campbell B, Gray PB, Sorenson MD. 2008. Dopamine receptor genetic polymorphisms and body composition in undernourished pastoralists: an exploration of nutrition indices among nomadic and recently settled Ariaal men of northern Kenya. BMC Evol. Biol. 8:173 http://bmcevolbiol.biomedcentral.com/articles/10.1186/1471-2148-8-173 [Google Scholar]
  14. Elder TE. 2010. The importance of relative standards in ADHD diagnoses: evidence based on exact birth dates. J. Health Econ. 29:641–56 [Google Scholar]
  15. Evans WN, Morrill MS, Parente ST. 2010. Measuring inappropriate medical diagnosis and treatment in survey data: the case of ADHD among school-age children. J. Health Econ. 29:657–73 [Google Scholar]
  16. First MB, Wakefield JC. 2013. Diagnostic criteria as dysfunction indicators: bridging the chasm between the definition of mental disorder and diagnostic criteria for specific disorders. Can. J. Psychiatry 58:12663–69 [Google Scholar]
  17. First MB, Wakefield JC. 2010. Defining “mental disorder” in DSM-V. Psychol. Med. 40:111779–82 [Google Scholar]
  18. Frances A. 1998. Problems in defining clinical significance in epidemiological studies. Arch. Gen. Psychiatry 55:2119 [Google Scholar]
  19. Frances A. 2009. A warning sign on the road to DSM-V: beware of its unintended consequences. Psychiatr. Times June 26. http://www.psychiatrictimes.com/articles/warning-sign-road-dsm-v-beware-its-unintended-consequences
  20. Frances AJ. 2010. DSM5 should not expand bipolar II disorder. Psychology Today Apr. 23. https://www.psychologytoday.com/blog/dsm5-in-distress/201004/dsm5-should-not-expand-bipolar-ii-disorder
  21. Frances A. 2011. Should temper tantrums be made into a DSM-5 diagnosis?. Psychiatr. Times Oct. 13. http://www.psychiatrictimes.com/blog/couchincrisis/content/article/10168/1970399
  22. Frances A. 2012. DSM-5 is a guide, not a bible: Simply ignore its 10 worst changes. Huffington Post Dec. 3. http://www.huffingtonpost.com/allen-frances/dsm-5_b_2227626.html
  23. Frances A. 2013. The new somatic symptom disorder in DSM-5 risks mislabeling many people as mentally ill. BMJ 346:f1580 [Google Scholar]
  24. Frances A, Jones KD. 2012. Bipolar disorder type II revisited. Bipolar Disord. 14:474–77 [Google Scholar]
  25. Fusar-Poli P, Van Os J. 2013. Lost in transition: setting the psychosis threshold in prodromal research. Acta Psychiatr. Scand. 127:248–52 [Google Scholar]
  26. Garvey M, Heinssein R, Pine DS, Quinn K, Sanislow C, Wang P. 2010. Research Domain Criteria (RDoC); toward a new classification framework for research on mental disorders. Am. J. Psychiatry 167:748–51 [Google Scholar]
  27. Gaudiano BA, Zimmerman M. 2013. Prevalence of attenuated psychotic symptoms and their relationship with DSM-IV diagnoses in a general psychiatric outpatient clinic. J. Clin. Psychiatry 74:2149–55 [Google Scholar]
  28. Ghaemi N. 2010. DSM-5 and bipolar disorder: science versus politics. Psychology Today Apr. 24. https://www.psychologytoday.com/blog/mood-swings/201004/dsm-5-and-bipolar-disorder-science-versus-politics
  29. Grossman R. 2008. Psychiatric manual's update needs openness, not secrecy, critics say: Edition is being prepared with strict oversight, officials counter. Chicago Tribune Dec. 27. http://articles.chicagotribune.com/2008-12-27/news/0812260126_1_secrecy-dsm-manual
  30. Hasin DS, O'Brien CP, Auriacombe M, Borges G, Bucholz K. et al. 2013. DSM-5 criteria for substance use disorders: recommendations and rationale. Am. J. Psychiatry 170:8834–51 [Google Scholar]
  31. Hill JC, Schoener EP. 1996. Age-dependent decline of attention deficit hyperactivity disorder. Am. J. Psychiatry 153:91143–46 [Google Scholar]
  32. Hinshaw SP, Scheffler RM. 2014. The ADHD Explosion New York: Oxford
  33. Hoge CW, Riviere LA, Wilk JE, Herrell RK, Weathers FW. 2014. The prevalence of post-traumatic stress disorder (PTSD) in US combat soldiers: a head-to-head comparison of DSM-5 versus DSM-IV-TR symptom criteria with the PTSD checklist. Lancet Psychiatry 1:4269–77 [Google Scholar]
  34. Kendler KS. 2013. A history of the DSM-5 Scientific Review Committee. Psychol. Med. 43:1793–800 [Google Scholar]
  35. Kendler KS, Appelbaum PS, Bell CC, Fulford KWM, Ghaemi SN. et al. 2008. Issues for DSM-V: DSM-V should include a conceptual issues work group. Am. J. Psychiatry 165:174–75 [Google Scholar]
  36. Kendler KS, Gardner CO. 1998. Boundaries of major depression: an evaluation of DSM-IV criteria. Am. J. Psychiatry 155:172–77 [Google Scholar]
  37. Kessler RC, Coccaro EF, Fava M, Jaeger S, Jin R, Walters E. 2006. The prevalence and correlates of DSM-IV intermittent explosive disorder in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 63:669–78 [Google Scholar]
  38. Kessler RC, Merikangas KR, Berglund P, Eaton WW, Koretz DS, Walters EE. 2003. Mild disorders should not be eliminated from the DSM-V. Arch. Gen. Psychiatry 60:1117–22 [Google Scholar]
  39. Kessler RC, Merikangas KR, Berglund P, Eaton WW, Koretz DS, Walters EE. 2004. In reply. Arch. Gen. Psychiatry 61:1051–52 [Google Scholar]
  40. Kessler RC, Rubinow D, Holmes C, Aberson J, Zhao S. 1997a. The epidemiology of DSM-III-R bipolar I disorder in a general population survey. Psychol. Med. 27:1079–89 [Google Scholar]
  41. Kessler RC, Zhao S, Blazer DG, Swartz M. 1997b. Prevalence, correlates, and course of minor depression and major depression in the National Comorbidity Survey. J. Affect. Disord. 45:1–219–30 [Google Scholar]
  42. Klein RG, Mannuzza S, Olazagasti MAR, Roizen E, Hutchison JA. et al. 2012. Clinical and functional outcome of childhood attention-deficit/hyperactivity disorder 33 years later. Arch. Gen. Psychiatry 69:121295–303 [Google Scholar]
  43. Lord C, Bishop SL. 2015. Recent advances in autism research as reflected in DSM-5 criteria for autism spectrum disorder. Annu. Rev. Clin. Psychol. 11:53–70 [Google Scholar]
  44. Maj M. 2013. “Clinical judgment” and the DSM-5 diagnosis of major depression. World Psychiatry 12:289–91 [Google Scholar]
  45. Mannuzza S, Klein RG. 2000. Long-term prognosis in attention-deficit/hyperactivity disorder. Child Adolesc. Psychiatry Clin. North Am. 9:3711–26 [Google Scholar]
  46. Mataix-Cols D, Billotti D, Fernandez de la Cruz L, Nordsletten AE. 2013. The London field trial for hoarding disorder. Psychol. Med. 43:837–47 [Google Scholar]
  47. McLaughlin KA, Green JG, Hwang I, Sampson NA, Zaslavsky AM, Kessler RC. 2012. Intermittent explosive disorder in the National Comorbidity Survey Replication Adolescent Supplement. Arch. Gen. Psychiatry 69:111131–39 [Google Scholar]
  48. McPartland JC, Reichow B, Volkmar FR. 2012. Sensitivity and specificity of proposed DSM-5 diagnostic criteria for autism spectrum disorder. J. Am. Acad. Child Adolesc. Psychiatry 51:4368–83 [Google Scholar]
  49. Mechanic D. 2003. Is the prevalence of mental disorders a good measure of the need for services?. Health Aff. 22:8–20 [Google Scholar]
  50. Moffitt TE, Caspi A, Taylor A, Kokaua J, Milne B. et al. 2010. How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment. Psychol. Med. 40:6899–909 [Google Scholar]
  51. Moffitt TE, Houts R, Asherson P, Belsky DW, Corcoran DL. et al. 2015. Is adult ADHD a childhood-onset neurodevelopmental disorder? Evidence from a four-decade longitudinal cohort study. Am. J. Psychiatry 172:10967–77 [Google Scholar]
  52. Mojtabai R. 2011. Bereavement-related depressive episodes: characteristics, 3-year course, and implications for DSM-5. Arch. Gen. Psychiatry 68:920–28 [Google Scholar]
  53. Moreno C, Laje G, Blanco C, Jiang H, Schmidt AB, Olfson M. 2007. National trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Arch. Gen. Psychiatry 64:1032–39 [Google Scholar]
  54. Narrow WE, Kuhl EA, Regier DA. 2009. DSM-V perspectives on disentangling disability from clinical significance. World Psychiatry 8:288–89 [Google Scholar]
  55. Narrow WE, Rae DS, Robins LN, Regier DA. 2002. Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys' estimates. Arch. Gen. Psychiatry 59:115–23 [Google Scholar]
  56. Nusslock R, Frank E. 2011. Subthreshold bipolarity: diagnostic issues and challenges. Bipolar Disord. 13:7–8587–603 [Google Scholar]
  57. Parkes C. 1964. Recent bereavement as a cause of mental illness. Br. J. Psychiatry 110:198–204 [Google Scholar]
  58. Pratt LA, Brody DJ, Gu Q. 2011. Antidepressant use in persons aged 12 and over: United States, 2005–2008. NCHS Data Brief No 76 Hyattsville, MD: Natl. Cent. Health Stat.
  59. Prigerson HG, Horowitz MJ, Jacobs SC, Parkes CM, Aslan M. et al. 2009. Prolonged grief disorder: psychometric validation of criteria proposed for DSM-V and ICD-11. PLOS Med. 6:e1000121 [Google Scholar]
  60. Regier DA. 2003. Mental disorder diagnostic theory and practical reality: an evolutionary perspective. Health Aff. 22:21–27 [Google Scholar]
  61. Regier DA, Kaelber CT, Rae DS, Farmer ME, Knauper B. et al. 1998. Limitations of diagnostic criteria and assessment instruments for mental disorders: implications for research and policy. Arch. Gen. Psychiatry 55:109–15 [Google Scholar]
  62. Regier DA, Narrow WE, Kuhl EA, Kupfer DJ. 2009. The conceptual development of DSM-5. Am. J. Psychiatry 166:6645–50 [Google Scholar]
  63. Regier DA, Narrow WE, Rae DS. 2004. For DSM-V, it's the “disorder threshold,” stupid. Arch. Gen. Psychiatry 61:1051 [Google Scholar]
  64. Rohde P, Lewinsohn PM, Klein DN, Seeley JR, Gau JM. 2013. Key characteristics of major depressive disorder occurring in childhood, adolescence, emerging adulthood, and adulthood. Clin. Psychol. Sci. 1:141–53 [Google Scholar]
  65. Ruggero CJ, Zimmerman M, Chelminski I, Young D. 2010. Borderline personality disorder and the misdiagnosis of bipolar disorder. J. Psychiatr. Res. 44:6405–8 [Google Scholar]
  66. Schatzberg AF, Scully JH, Kupfer DJ, Regier DA. 2009. Setting the record straight: a response to Frances commentary on DSM-V. Psychiatr. Times July 1. http://www.psychiatrictimes.com/dsm/content/article/10168/1425806
  67. Schneider ME. 2009. DSM-V Task Force weighing changes. Clin. Psychiatry News 3:1–4 [Google Scholar]
  68. Schwartz PH. 2008. Risk and disease. Perspect. Biol. Med. 51:320–34 [Google Scholar]
  69. Shaw P, Eckstrand K, Sharp W, Blumenthal J, Lerch JP. et al. 2007. Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. PNAS 104:19649–54 [Google Scholar]
  70. Shaw P, Malek M, Watson B, Greenstein D, de Rossi P, Sharp W. 2013. Trajectories of cerebral cortical development in childhood and adolescence and adult attention-deficit/hyperactivity disorder. Biol. Psychiatry 74:599–606 [Google Scholar]
  71. Shear MK, Simon N, Wall M, Zisook S, Neimeyer R. et al. 2011. Complicated grief and related bereavement issues for DSM-5. Depress. Anxiety 28:103–17 [Google Scholar]
  72. Simon AE, Riecher-Rössler A, Lang UE, Borgwardt S. 2013. The attenuated psychosis syndrome in DSM-5. Schizophr. Res. 151:295 [Google Scholar]
  73. Spitzer RL. 2008. DSM-V: open and transparent?. Psychiatr. News 43:1426 [Google Scholar]
  74. Spitzer RL. 2009a. DSM-V transparency: fact or rhetoric?. Psychiatr. Times March 6. http://www.psychiatrictimes.com/articles/dsm-v-transparency-fact-or-rhetoric
  75. Spitzer RL. 2009b. APA and DSM-V: empty promises. Psychiatr. Times July 2. http://www.psychiatrictimes.com/articles/apa-and-dsm-v-empty-promises
  76. Spitzer RL, Wakefield JC. 1999. DSM-IV diagnostic criterion for clinical significance: Does it help solve the false positives problem?. Am. J. Psychiatry 156:1856–64 [Google Scholar]
  77. Sripada CS, Kessler D, Angstadt M. 2014. Lag in maturation of the brain's intrinsic functional architecture in attention-deficit/hyperactivity disorder. PNAS 111:3914259–64 [Google Scholar]
  78. Stotland N. 2009. Here's a secret: the DSM process isn't. Psychiatr. News Feb. 6. http://psychnews.psychiatryonline.org/doi/full/10.1176/pn.44.3.0003
  79. Ustun B, Kennedy C. 2009. What is “functional impairment”? Disentangling disability from clinical significance. World Psychiatry 8:82–85 [Google Scholar]
  80. Visser SN, Danielson ML, Bitsko RH, Holbrook JR, Kogan MD. et al. 2014. Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003-2011. J. Am. Acad. Child Adolesc. Psychiatry 53:134–46.e2 [Google Scholar]
  81. Wakefield JC. 1992a. The concept of mental disorder: on the boundary between biological facts and social values. Am. Psychol. 47:373–88 [Google Scholar]
  82. Wakefield JC. 1992b. Disorder as harmful dysfunction: a conceptual critique of DSM-III-R's definition of mental disorder. Psychol. Rev. 99:232–47 [Google Scholar]
  83. Wakefield JC. 1993. Limits of operationalization: a critique of Spitzer and Endicott's 1978 proposed operational criteria for mental disorder. J. Abnorm. Psychol. 102:160–72 [Google Scholar]
  84. Wakefield JC. 1996. DSM-IV: Are we making diagnostic progress?. Contemp. Psychol. 41:646–52 [Google Scholar]
  85. Wakefield JC. 1997a. Diagnosing DSM-IV, part 1: DSM-IV and the concept of mental disorder. Behav. Res. Ther. 35:633–50 [Google Scholar]
  86. Wakefield JC. 1997b. Diagnosing DSM-IV, part 2: Eysenck 1986 and the essentialist fallacy. Behav. Res. Ther. 35:651–66 [Google Scholar]
  87. Wakefield JC. 1999a. Evolutionary versus prototype analyses of the concept of disorder. J. Abnorm. Psychol. 108:374–99 [Google Scholar]
  88. Wakefield JC. 1999b. Disorder as a black box essentialist concept. J. Abnorm. Psychol. 108:465–72 [Google Scholar]
  89. Wakefield JC. 2006. The concept of mental disorder: Diagnostic implications of the harmful dysfunction analysis. World Psychiatry 6:149–56 [Google Scholar]
  90. Wakefield JC. 2009. Disability and diagnosis: Should role impairment be eliminated from DSM/ICD diagnostic criteria?. World Psychiatry 8:87–88 [Google Scholar]
  91. Wakefield JC. 2010. False positives in psychiatric diagnosis: implications for human freedom. Theor. Med. Bioeth. 31:15–17 [Google Scholar]
  92. Wakefield JC. 2012. Should prolonged grief be reclassified as a mental disorder in DSM-5? Reconsidering the empirical and conceptual arguments for proposed grief disorders. J. Nerv. Ment. Dis. 200:499–511 [Google Scholar]
  93. Wakefield JC. 2013a. The DSM-5 debate over the bereavement exclusion: psychiatric diagnosis and the future of empirically supported practice. Clin. Psychol. Rev. 33:825–45 [Google Scholar]
  94. Wakefield JC. 2013b. DSM-5 and clinical social work: mental disorder and psychological justice as goals of clinical intervention. Clin. Soc. Work J. 41:2131–38 [Google Scholar]
  95. Wakefield JC. 2013c. DSM-5 and the general definition of personality disorder. Clin. Soc. Work J. 41:2168–83 [Google Scholar]
  96. Wakefield JC. 2014. Wittgenstein's nightmare: why the RDoC grid needs a conceptual dimension. World Psychiatry 13:138–40 [Google Scholar]
  97. Wakefield JC. 2015a. Psychological justice: DSM-5, false positive diagnosis, and fair equality of opportunity. Public Aff. Q. 29:132–75 [Google Scholar]
  98. Wakefield JC. 2015b. DSM-5 substance use disorder: how conceptual missteps weakened the foundations of the addictive disorders field. Acta Psychiatr. Scand. 132:5327–34 [Google Scholar]
  99. Wakefield JC, First MB. 2012a. Placing symptoms in context: the role of contextual criteria in reducing false positives in DSM diagnosis. Compr. Psychiatry 53:130–39 [Google Scholar]
  100. Wakefield JC, First MB. 2012b. Does the empirical evidence support the proposal to eliminate the major depression “bereavement exclusion” in DSM-5?. World Psychiatry 11:3–10 [Google Scholar]
  101. Wakefield JC, First MB. 2013a. Clarifying the boundary between normality and disorder: a fundamental conceptual challenge for psychiatry. Can. J. Psychiatry 58:11603–5 [Google Scholar]
  102. Wakefield JC, First MB. 2013b. Diagnostic validity and the definition of mental disorder: a program for conceptually advancing psychiatry. Can. J. Psychiatry 58:12653–55 [Google Scholar]
  103. Wakefield JC, Schmitz MF. 2012. Recurrence of bereavement-related depression: evidence for the validity of the DSM-IV bereavement exclusion from the Epidemiologic Catchment Area Study. J. Nerv. Ment. Dis. 200:480–85 [Google Scholar]
  104. Wakefield JC, Schmitz MF. 2013a. Normal versus disordered bereavement-related depression: Are the differences real or tautological?. Acta Psychiatr. Scand. 127:159–68 [Google Scholar]
  105. Wakefield JC, Schmitz MF. 2013b. Can the DSM's major depression bereavement exclusion be validly extended to other stressors? Evidence from the NCS. Acta Psychiatr. Scand. 128:294–305 [Google Scholar]
  106. Wakefield JC, Schmitz MF. 2013c. When does depression become a disorder? Using recurrence rates to evaluate the validity of proposed changes in major depression diagnostic thresholds. World Psychiatry 12:44–52 [Google Scholar]
  107. Wakefield JC, Schmitz MF. 2014a. Predictive validation of single-episode uncomplicated depression as a benign subtype of unipolar major depression. Acta Psychiatr. Scand. 129:445–57 [Google Scholar]
  108. Wakefield JC, Schmitz MF. 2014b. Uncomplicated depression, suicide attempt, and the DSM-5 bereavement-exclusion debate: an empirical evaluation. Res. Soc. Work Pract. 24:137–49 [Google Scholar]
  109. Wakefield JC, Schmitz MF. 2014c. How many people have alcohol use disorders? Using the harmful dysfunction analysis to reconcile prevalence estimates in two community surveys. Front. Psychiatry 5:10 [Google Scholar]
  110. Wakefield JC, Schmitz MF. 2015. The harmful dysfunction model of alcohol use disorder: revised criteria to improve the validity of diagnosis and prevalence estimates. Addiction 110:6931–42 [Google Scholar]
  111. Wakefield JC, Schmitz MF, Baer JC. 2010. Does the DSM-IV clinical significance criterion for major depression reduce false positives? Evidence from the NCS-R. Am. J. Psychiatry 167:298–304 [Google Scholar]
  112. Wakefield JC, Schmitz MF, First MB, Horwitz AV. 2007. Should the bereavement exclusion for major depression be extended to other losses? Evidence from the National Comorbidity Survey. Arch. Gen. Psychiatry 64:433–40 [Google Scholar]
  113. Wakefield JC, Spitzer RL. 2002. Lowered estimates—but of what?. Arch. Gen. Psychiatry 59:129–30 [Google Scholar]
  114. Woods SW, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA. et al. 2009. Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr. Bull. 35:5894–908 [Google Scholar]
  115. WHO (World Health Organ.) 2004. International Statistical Classification of Diseases and Related Health Problems Geneva: WHO, 10th rev., 2nd ed..
  116. Zimmerman M, Chelminski I, Young D. 2004. On the threshold of disorder: a study of the impact of the DSM-IV clinical significance criterion on diagnosing depressive and anxiety disorders in clinical practice. J. Clin. Psychiatry 65:101400–5 [Google Scholar]
  117. Zimmerman M, Ruggero CJ, Chelminski I, Young D. 2008. Is bipolar disorder overdiagnosed?. J. Clin. Psychiatry 69:6935–40 [Google Scholar]
  118. Zoëga H, Valdimarsdóttir UA, Hernández-Díaz S. 2012. Age, academic performance, and stimulant prescribing for ADHD: a nationwide cohort study. Pediatrics 130:1012–18 [Google Scholar]
  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error